Cargando…
Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis
Nonalcoholic fatty liver disease (NAFLD) is associated with impaired hepatic actions of glucagon and insulin. Glucagon and amino acids are linked in an endocrine feedback circuit, the liver–alpha cell axis, that may be disrupted by NAFLD. We investigated how NAFLD severity affects glucagon and insul...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603528/ https://www.ncbi.nlm.nih.gov/pubmed/33163832 http://dx.doi.org/10.1002/hep4.1562 |
_version_ | 1783603942418022400 |
---|---|
author | Pedersen, Julie Steen Rygg, Marte Opseth Kristiansen, Viggo Bjerregaard Olsen, Beth Hærstedt Serizawa, Reza Rafiolsadat Holst, Jens Juul Madsbad, Sten Gluud, Lise Lotte Bendtsen, Flemming Wewer Albrechtsen, Nicolai Jacob |
author_facet | Pedersen, Julie Steen Rygg, Marte Opseth Kristiansen, Viggo Bjerregaard Olsen, Beth Hærstedt Serizawa, Reza Rafiolsadat Holst, Jens Juul Madsbad, Sten Gluud, Lise Lotte Bendtsen, Flemming Wewer Albrechtsen, Nicolai Jacob |
author_sort | Pedersen, Julie Steen |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is associated with impaired hepatic actions of glucagon and insulin. Glucagon and amino acids are linked in an endocrine feedback circuit, the liver–alpha cell axis, that may be disrupted by NAFLD. We investigated how NAFLD severity affects glucagon and insulin resistance in individuals with obesity and whether bariatric surgery improves these parameters. Plasma and liver biopsies from 33 individuals with obesity (collectively, OBE) were obtained before and 12 months after bariatric surgery (Roux‐en‐Y gastric bypass [RYGB] or sleeve gastrectomy [SG]). Nine healthy control individuals (collectively, CON) undergoing cholecystectomy were used as a comparison group. The NAFLD activity score (NAS) was used to subdivide study participants into the following groups: OBE‐no steatosis, OBE+steatosis, and nonalcoholic steatohepatitis (NASH) and/or grade 2 fibrosis (Fib) (OBE‐NASH‐Fib). Measurements of amino acids by targeted metabolomics and glucagon were performed. Glucagon, amino acids (P < 0.05), and the glucagon‐alanine index, a validated surrogate marker of glucagon resistance, were increased in OBE by 60%, 56%, and 61%, respectively, when compared with CON but irrespective of NAFLD severity. In contrast, markers of hepatic insulin resistance increased concomitantly with NAS. Hyperglucagonemia resolved in OBE‐no steatosis and OBE+steatosis but not in OBE‐NASH‐Fib (median, 7.0; interquartile range, 5.0‐9.8 pmol/L), regardless of improvement in insulin resistance and NAS. The type of surgery that participants underwent had no effect on metabolic outcomes. Conclusion: Glucagon resistance to amino acid metabolism exists in individuals with NAFLD independent of NAS severity. Patients with NASH showed persistent hyperglucagonemia 12 months after bariatric surgery, indicating that a disrupted liver–alpha cell may remain in NAFLD despite major improvement in liver histology. |
format | Online Article Text |
id | pubmed-7603528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76035282020-11-05 Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis Pedersen, Julie Steen Rygg, Marte Opseth Kristiansen, Viggo Bjerregaard Olsen, Beth Hærstedt Serizawa, Reza Rafiolsadat Holst, Jens Juul Madsbad, Sten Gluud, Lise Lotte Bendtsen, Flemming Wewer Albrechtsen, Nicolai Jacob Hepatol Commun Original Articles Nonalcoholic fatty liver disease (NAFLD) is associated with impaired hepatic actions of glucagon and insulin. Glucagon and amino acids are linked in an endocrine feedback circuit, the liver–alpha cell axis, that may be disrupted by NAFLD. We investigated how NAFLD severity affects glucagon and insulin resistance in individuals with obesity and whether bariatric surgery improves these parameters. Plasma and liver biopsies from 33 individuals with obesity (collectively, OBE) were obtained before and 12 months after bariatric surgery (Roux‐en‐Y gastric bypass [RYGB] or sleeve gastrectomy [SG]). Nine healthy control individuals (collectively, CON) undergoing cholecystectomy were used as a comparison group. The NAFLD activity score (NAS) was used to subdivide study participants into the following groups: OBE‐no steatosis, OBE+steatosis, and nonalcoholic steatohepatitis (NASH) and/or grade 2 fibrosis (Fib) (OBE‐NASH‐Fib). Measurements of amino acids by targeted metabolomics and glucagon were performed. Glucagon, amino acids (P < 0.05), and the glucagon‐alanine index, a validated surrogate marker of glucagon resistance, were increased in OBE by 60%, 56%, and 61%, respectively, when compared with CON but irrespective of NAFLD severity. In contrast, markers of hepatic insulin resistance increased concomitantly with NAS. Hyperglucagonemia resolved in OBE‐no steatosis and OBE+steatosis but not in OBE‐NASH‐Fib (median, 7.0; interquartile range, 5.0‐9.8 pmol/L), regardless of improvement in insulin resistance and NAS. The type of surgery that participants underwent had no effect on metabolic outcomes. Conclusion: Glucagon resistance to amino acid metabolism exists in individuals with NAFLD independent of NAS severity. Patients with NASH showed persistent hyperglucagonemia 12 months after bariatric surgery, indicating that a disrupted liver–alpha cell may remain in NAFLD despite major improvement in liver histology. John Wiley and Sons Inc. 2020-09-01 /pmc/articles/PMC7603528/ /pubmed/33163832 http://dx.doi.org/10.1002/hep4.1562 Text en © 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Pedersen, Julie Steen Rygg, Marte Opseth Kristiansen, Viggo Bjerregaard Olsen, Beth Hærstedt Serizawa, Reza Rafiolsadat Holst, Jens Juul Madsbad, Sten Gluud, Lise Lotte Bendtsen, Flemming Wewer Albrechtsen, Nicolai Jacob Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis |
title | Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis |
title_full | Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis |
title_fullStr | Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis |
title_full_unstemmed | Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis |
title_short | Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis |
title_sort | nonalcoholic fatty liver disease impairs the liver–alpha cell axis independent of hepatic inflammation and fibrosis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603528/ https://www.ncbi.nlm.nih.gov/pubmed/33163832 http://dx.doi.org/10.1002/hep4.1562 |
work_keys_str_mv | AT pedersenjuliesteen nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT ryggmarteopseth nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT kristiansenviggobjerregaard nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT olsenbethhærstedt nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT serizawarezarafiolsadat nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT holstjensjuul nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT madsbadsten nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT gluudliselotte nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT bendtsenflemming nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis AT weweralbrechtsennicolaijacob nonalcoholicfattyliverdiseaseimpairstheliveralphacellaxisindependentofhepaticinflammationandfibrosis |